Latest Breaking News On - Prnewswire kyverna therapeutics inc - Page 1 : comparemela.com

Kyverna Therapeutics to attend the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, CO, With Data on KYV-101 in the Treatment of Patients with Neurological Autoimmune Diseases

/PRNewswire/ Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies.

United statesNordrhein westfalenPeter maagLily sarafanJeffrey dunnMarinos dalakasUniversity hospitalNational institutes of healthAmerican academy of neurologyExchange commissionThomas jefferson university hospitalsPrnewswire kyverna therapeutics incKyverna therapeutics incDepartment of neurologyAmerican academyJeremias motte

Kyverna Therapeutics To Attend The 2024 American Academy Of Neurology (AAN) Annual Meeting In Denver, CO, With Data On KYV-101 In The Treatment Of Pat

Kyverna Therapeutics To Attend The 2024 American Academy Of Neurology (AAN) Annual Meeting In Denver, CO, With Data On KYV-101 In The Treatment Of Pat
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesNordrhein westfalenPeter maagMarinos dalakasJeffrey dunnLily sarafanDepartment of neurologyAmerican academy of neurologyUniversity hospitalThomas jefferson university hospitalsNational institutes of healthPrnewswire kyverna therapeutics incKyverna therapeutics incExchange commissionAmerican academyJeremias motte

Kyverna Therapeutics Provides Business Update and Reports Full Year 2023 Financial Results

Kyverna Therapeutics Provides Business Update and Reports Full Year 2023 Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesElevatebio basecampGeorge thampyDennis riedlKyverna ingenuiPeter maagCompany annual report on formKyverna therapeutics incPrnewswire kyverna therapeutics incChief executive officerRecent businessTrack designationsYear ended decemberKyverna therapeuticsRisk factorsAnnual report

Kyverna Therapeutics Provides Business Update and Reports Full Year 2023 Financial Results

Advanced clinical development in two broad areas of autoimmune disease: rheumatology and neurologyStrong balance sheet, bolstered by recent public offering, expected to fund operations into.

United statesGeorge thampyKyverna ingenuiPeter maagElevatebio basecampCompany annual report on formPrnewswire kyverna therapeutics incKyverna therapeutics incChief executive officerRecent businessTrack designationsYear ended decemberKyverna therapeuticsRisk factorsAnnual reportEnded december

Kyverna Therapeutics Congratulates Prof G Schett et al on the Publication of a Case Series Follow-up of 15 Patients Living with Autoimmune Disease Treated With CAR T-Cell Therapy

Kyverna Therapeutics Congratulates Prof G Schett et al on the Publication of a Case Series Follow-up of 15 Patients Living with Autoimmune Disease Treated With CAR T-Cell Therapy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesGeorg schettPeter maagErlangen department of medicinePrnewswire kyverna therapeutics incScientific advisory boardNew england journalMedia contact